Vessel health and preservation (Part 1): a new evidence-based approach to vascular access selection and management

Nancy L Moureau, Nancy Trick, Thomas Nifong, Cathy Perry, Cheryl Kelley, Ruth Carrico, Michael Leavitt, Steven M Gordon, Jessica Wallace, Monte Harvill, Connie Biggar, Michael Doll, Loreli Papke, Lori Benton, Deborah A Phelan, Nancy L Moureau, Nancy Trick, Thomas Nifong, Cathy Perry, Cheryl Kelley, Ruth Carrico, Michael Leavitt, Steven M Gordon, Jessica Wallace, Monte Harvill, Connie Biggar, Michael Doll, Loreli Papke, Lori Benton, Deborah A Phelan

Abstract

Vascular access for the infusion of medications and solutions requires timely assessment, planning, insertion, and assessment. Traditional vascular access is reactive, painful, and ineffective, often resulting in the exhaustion of peripheral veins prior to consideration of other access options. Evidence suggests clinical pathways improve outcomes by reducing variations and establishing processes to assess and coordinate care, minimizing fragmentation and cost. Implementation of a vascular access clinical pathway leads to the intentional selection of the best vascular access device for the patient specific to the individual diagnosis, treatment plan, current medical condition, and the patient's vessel health (1). The Vessel Health and Preservation (VHP) programme incorporates evidence-based practices focused on timely, intentional proactive device selection implemented within 24 hours of admission into any acute facility. VHP is an all-inclusive clinical pathway, guiding clinicians from device selection through patient discharge, including daily assessment. Initiation of the VHP programme within a facility provides a systematic pathway to improve vascular access selection and patient care, allowing for the reduction of variations and roadblocks in care while increasing positive patient outcomes and satisfaction. Patient safety and preservation of vessel health is the ultimate goal.

References

    1. Hanchett M., Poole S. Infusion Pathways: Planning for Success. JVAD. 2001; 6(3): 29–37.
    1. Pocketsonics. Introduction. 2011; . Accessed Aug 31, 2011.
    1. Joint Commission. Accreditation Program: Home Care National Patient Safety Goals (2009). In: Div S.S.M., ed: Joint Commission; 2009: 1–13.
    1. CDC. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. Centers for Disease Control. 2011: 1–83.
    1. O'Grady N., Alexander M., Dellinger E. et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. Aug 9 2002; 51(RR-10): 1–26.
    1. Joint Commission. Improving America's Hospitals: The Joint Commission's Annual Report on Quality and Safety, Quality and Safety. NPSG. 2009: 2–16.
    1. Ryder M. Peripherally Inserted Central Venous Catheters. Nurs Clin North Am. 1993; 28(4): 937–971.
    1. Kokotis K. Cost containment and infusion services. J Infus Nurs. 2005; 28(3 Suppl): S22–32; quiz S33-26.
    1. Barton A., Danek G., Johns P., Coons M. Improving Patient Outcomes through CQI: Vascular Access Planning (The Clinical Impact of Cost Reduction). J Nurs Care Qual. December 1998; 13(2): 77–85.
    1. Moureau N.L., Bagnall-Trick N., Nichols H., Moureau G. Forge New Pathways: Following an intentional process for early assessment of vascular access selection for patients requiring intravenous therapy. Nurs Crit Care. 2007. 2(6): 28–36.
    1. INS. Infusion Nursing Standards of Practice. J Infus Nurs. 2011; 34(1S): S1–110.
    1. Segreti J., Garcia-Houchins S., Gorski L. et al. Consensus Conference on Prevention of Central Line-Associated Bloodstream Infections: 2009. J Infus Nurs. 2011; 34(2): 126–133.
    1. Panella M., Marchisio S., Di Stanislao F. Reducing Clinical Variations With Clinical Pathways: Do Pathways Work? Int J Qual Health Care. 2003; 15(6): 509–521.
    1. Hoggard J., Saad T., Schon D., Vesely T., Royer T. Guideline for Venous Access in Patients with Chronic Kidney Disease: A Position Statement from the American Society of Diagnostic and Interventional Nephrology Clinical Practice Committee and the Association for Vascular Access. Semin Dial. 2008; 21(2): 186–191.
    1. INS. Infusion Nursing Standards of Practice. J Infus Nurs. 2006; 29(1S): S1–92.
    1. AVA. SAVE That Line! 2005 accessed September 1, 2011.
    1. SHEA. SHEA Guidelines. 2008. Accessed September 1, 2011.
    1. IHI. Implementing the Central Line Bundle. Institute for Healthcare Improvement. 2009. Accessed September 1, 2011.
    1. AHRQ. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Summary. Agency for Healthcare Research and Quality. Jul 2001; 43.
    1. RNAO. Nursing Best Practice Guidelines Program: Care and Maintenance to Reduce Vascular Access Complications. 2005: 1–91.
    1. APIC. Association for Professionals in Infection Control and Epidemiology. 2011.
    1. da Silva G.A., Priebe S., Dias F.N. Benefits of Establishing an Intravenous Team and the Standardization of Peripheral Intravenous Catheters. J Infus Nurs. 2010 2010; 33(3): 156–160.
    1. Brunelle D. Impact of a Dedicated Infusion Therapy Team on the Reduction of Catheter-related Nosocomial Infections. J Infus Nurs. 2003; 26(6): 362–366.
    1. Robinson M., Mogensen K., Grudinskas G., Kohler S., Jacobs D. Improved care and reduced costs for patients requiring peripherally inserted central catheters: the role of bedside ultrasound and a dedicated team. JPEN J Parenter Enteral Nutr. 2005; 29(5): 374–379.
    1. Royer T. Implementing a Better Bundle to Achieve and Sustain a Zero Central Line-Associated Bloodstream Infection Rate. J Infus Nurs. 2010; 33(6): 398–406.
    1. Eggimann P., Harbath S., Constantin M., Touveneau S., Chevrolet J., Pittet D. Impact of a prevention strategy targeted at vascular access care on incidence of infections acquired in intensive care. Lancet. Mary 27, 2000; 355: 1864–1868.
    1. Sheretz R., Ely E., Westbrook D. et al. Education of Physicians-in-Training Can Decrease the Risk for Vascular Catheter Infection. Ann Intern Med. 2000; 132(8): 641–648.
    1. Warren D., Zack J., Cox M., Cohen M., Fraser V. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003 2003; 31(7): 1959–1963.
    1. Warren D., Zack J., Mayfield J. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest. 2004; 126(5): 1612–1618.
    1. Coopersmith C., Rebmann T., Zack J. et al. Effect of an education program on decreasing catheter related bloodstream infections in the surgical intensive care unit. Crit Care Med. 2002; 30(1): 59–64.
    1. Joint Commission. National Patient Safety goal: NPSG 07.04.01 (Effective Jul 1, 2011). 2011.
    1. INS. Infusion Nursing Standards of Practice. J Infus Nurs. 2006; 29(1 Suppl): S1–92.
    1. Marschall J., Mermel L., Classen D. et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29(Suppl 1): S22–30.
    1. Camp-Sorrell D. Access Device Guidelines: Recommendations for Nursing Practice and Education, 2nd Edition. ONS News; 2011: 170.
    1. Harnage S. Achieving Zero Catheter Related Blood Stream Infections: 15 Months Success in a Community Based Medical Center. JAVA. 2007; 12(4): 218–224.
    1. Harnage S. Innovative Central Line Bundle Achieves Zero Rate of CRBSIs for 33 Months. 2009.
    1. Moureau N., Maney S. Legal Aspects of Infusion Nursing. JVAD. Spring 2003. 2003: 8–11.
    1. Spader C. IV Insertion - Still a Special Skill: an interview with Sue Masoorli. Nurse Week Spectrum. 2006.
    1. Wolosin R. Largest Study of Patient Satisfaction Ever Conducted. The Press Ganey SATISFACTION Report. Aug 2003; VII: 1–4.
    1. Danek G., Kilroy R. IV-CQI study: impact of a vascular access planning algorithm on patient outcomes. Friday's Focus. 1998; 8(19): 4–8.
    1. Santolucito J. A Retrospective Evaluation of the Timeliness of Physician-Initiated PICC Referrals: A Continuous Quality Assurance/Performance Improvement Study. J Vasc Access. 2001; 6(3): 20–26.
    1. IV Infiltration costs hospital $650,000. Healthcare Risk Manager Legal Rev Commentary. 1997; 19(5).
    1. Curtis J., Cook D., Wall R. et al. Intensive care unit quality improvement: A “how to” guide for the interdisciplinary team. Crit Care Med. 2006; 34(1): 211–218.
    1. Joint Commission. Accreditation Program: 2012 Hospital National Patient Safety Goals. In: Commission TJ, ed 2011: 1–24.
    1. ONS. Access Device Guidelines: Recommendations for Nursing Practice and Education (3rd Edition). Oncol Nursing. 2011.
    1. RNAO. Nursing Best Practice Guideline: Assessment and Device Selection for Vascular Access. Registered Nurses Association of Ontario. 2004. Accessed September 1, 2011.
    1. ASDIN. EAmerican Society of Diagnostic & Interventional Nephrology . Accessed Aug 31, 2011.
    1. iData Research I. US Market on Vascular Access Devices and Accessories. Vancouver British Columbia: iData; 2008.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅